Thrombosis
News
Rivaroxaban tied to higher GI bleeding than other NOACs
SAN DIEGO – Real-world studies comparing the GI bleeding rates among different non–vitamin K anticoagulants have been limited.
All Content
Subsegmental PEs overtreated despite link with patient harm
How often are physicians treating isolated subsegmental pulmonary embolisms?
All Content
Posthospitalization thromboprophylaxis with rivaroxaban is unnecessary
Do symptomatic venous thromboembolism (VTE) complications improve with posthospitalization thromboprophylaxis using rivaroxaban for an at-risk...
Clinical
Rivaroxaban versus heparin at preventing recurrent, cancer-related VTE
Is an oral direct factor Xa inhibitor an effective alternative to low-molecular-weight heparin (LMWH) in treating cancer related venous...
Latest News for HOSP
IVC filter placement increases mortality in some VTE patients
How does inferior vena cava (IVC) filter placement affect 30-day mortality in patients with venous thromboembolism (VTE) with increased risk of...
News
Ticagrelor reversal agent looks promising
NEW ORLEANS – Ticagrelor’s antiplatelet effect was squelched within 5 minutes.
News
Occurrence of pulmonary embolisms in hospitalized patients nearly doubled during 2004-2015
NEW ORLEANS – National Inpatient Sample data showed that during 2004-2015 hospitalized U.S. patients with a PE diagnosis jumped by 80%.
News
Andexanet alfa effectively reverses factor Xa inhibition
HONOLULU – The drug establishes good or excellent hemostasis in 82% of patients with acute major bleeding associated...
News
Supplementary compression doesn’t improve DVT odds in critically ill
SAN DIEGO – The procedure carries few risks, aside from patient discomfort.
News
PERT alerts improve pulmonary embolism outcomes
SAN DIEGO – Alerts that prompt multidisciplinary consultations cut death rates, ICU times in pulmonary embolism patients.